RenuTend

Authorised

This medicine is authorised for use in the European Union

tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  RenuTend
• Active substance:
  tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells
• International non-proprietary name (INN) or common name:
  tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells

Pharmacotherapeutic group

• Musculo-skeletal system
• Other drugs for disorders of the musculo-skeletal system

Authorisation details

• EMA product number:
  EMEA/V/C/005428

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for RenuTend

AdoptedReference Number: EMA/CVMP/73401/2022